Drug name - Nuzyra
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7553828 | PARATEK PHARMS INC | 9-aminomethyl substituted minocycline compounds |
Jun, 2023
(7 months from now) | |
| US7326696 | PARATEK PHARMS INC | Amino-methyl substituted tetracycline compounds |
Sep, 2023
(11 months from now) | |
| US8383610 | PARATEK PHARMS INC | Salts and polymorphs of 9-(2,2-dimethylpropyl-aminomethyl) minocycline |
Sep, 2030
(7 years from now) | |
| CN1649582A | PARATEK PHARMS INC | Amino-Methyl Substituted Tetracycline Compounds |
May, 2012
(10 years ago) | |
| CN1690047B | PARATEK PHARMS INC | 9-Substituted Minocycline Compounds |
Aug, 2014
(8 years ago) | |
| CN1690047A | PARATEK PHARMS INC | 9-Substituted Minocycline Compounds |
Aug, 2014
(8 years ago) | |
| CN105348138A | PARATEK PHARMS INC | Salt And Polymorph Of Tetracycline Compound |
Aug, 2018
(4 years ago) | |
| CN100473644C | PARATEK PHARMS INC | 9-Substituted Minocycline Compounds |
Jun, 2021
(1 year, 3 months ago) | |
| CN1471509A | PARATEK PHARMS INC | 9-Substituted Minocycline Compounds |
Jun, 2021
(1 year, 3 months ago) | |
| CN102105058B | PARATEK PHARMS INC | Salt And Polymorph Of Tetracycline Compound |
May, 2029
(6 years from now) | |
| CN102105058A | PARATEK PHARMS INC | Salts And Polymorphs Of A Tetracycline Compound |
May, 2029
(6 years from now) | |
| CN104844472B | PARATEK PHARMS INC | Salts And Polymorphs Of A Tetracycline Compound |
May, 2029
(6 years from now) | |
| CN104844472A | PARATEK PHARMS INC | Salts And Polymorphs Of A Tetracycline Compound |
May, 2029
(6 years from now) | |
| IN200402212P4 | PARATEK PHARMS INC | Amino-Methyl Substituted Tetracycline Compounds |
Mar, 2023
(5 months from now) | |
| IN228816B | PARATEK PHARMS INC | Amino-Methyl Substituted Tetracycline Compound |
Mar, 2023
(5 months from now) | |
| EP2308832A1 | PARATEK PHARMS INC | 9-Substituted Minocycline Compounds |
Jun, 2021
(1 year, 3 months ago) | |
| EP2308832B1 | PARATEK PHARMS INC | 9-Substituted Minocycline Compounds |
Jun, 2021
(1 year, 3 months ago) | |
| EP2308832B8 | PARATEK PHARMS INC | 9-Substituted Minocycline Compounds |
Jun, 2021
(1 year, 3 months ago) | |
| EP1301467A2 | PARATEK PHARMS INC | 9-Substituted Minocycline Compounds |
Jun, 2021
(1 year, 3 months ago) | |
| EP1301467B1 | PARATEK PHARMS INC | 9-Substituted Minocycline Compounds |
Jun, 2021
(1 year, 3 months ago) | |
| EP1679305A1 | PARATEK PHARMS INC | 9-Substituted Minocycline Compounds |
Jun, 2021
(1 year, 3 months ago) | |
| EP1679305B1 | PARATEK PHARMS INC | 9-Substituted Minocycline Compounds |
Jun, 2021
(1 year, 3 months ago) | |
| EP2296464A4 | PARATEK PHARMS INC | Salts And Polymorphs Of A Tetracycline Compound |
May, 2029
(6 years from now) | |
| EP2296464A1 | PARATEK PHARMS INC | Salts And Polymorphs Of A Tetracycline Compound |
May, 2029
(6 years from now) | |
| EP2807926B1 | PARATEK PHARMS INC | Salts And Plymorphs Of A Tetracycline Compound |
May, 2029
(6 years from now) | |
| EP2807926A1 | PARATEK PHARMS INC | Salts And Plymorphs Of A Tetracycline Compound |
May, 2029
(6 years from now) | |
| EP2296464B1 | PARATEK PHARMS INC | Salts And Polymorphs Of A Tetracycline Compound |
May, 2029
(6 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10124014 | PARATEK PHARMS INC | Minocycline compounds and methods of use thereof |
Mar, 2029
(6 years from now) | |
| US9724358 | PARATEK PHARMS INC | Minocycline compounds and methods of use thereof |
Mar, 2029
(6 years from now) | |
| US9265740 | PARATEK PHARMS INC | Minocycline compounds and methods of use thereof |
Mar, 2029
(6 years from now) | |
| US9314475 | PARATEK PHARMS INC | Oral and injectable formulations of tetracycline compounds |
Mar, 2031
(8 years from now) | |
| US10111890 | PARATEK PHARMS INC | 9-aminomethyl minocycline compounds and uses thereof |
Aug, 2037
(14 years from now) | |
| US10835542 | PARATEK PHARMS INC | 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP) |
Oct, 2037
(15 years from now) | |
| US10383884 | PARATEK PHARMS INC | 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP) |
Oct, 2037
(15 years from now) | |
Drugs and Companies using OMADACYCLINE TOSYLATE ingredient
Treatment: Treatment of bacterial skin and skin structure infection; Treatment of bacterial skin and skin structure infections; Treatment of subjects having bacterial skin or skin structure infection; Treatment of community acquired bacterial pneumonia
Dosage: POWDER;INTRAVENOUS
| Strength | Dosage | Availability |
|---|---|---|
| EQ 100MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.